Close Menu

Moffitt Cancer Center

Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns.

While some groups have communicated their concerns directly to the agency, stakeholders have also formed a new coalition to publicly take issue with FDA's actions.

Pharmacogenetics and legal experts took particular issue with the agency's suggestion that "established" drug/gene relationships are found only in FDA-approved drug labels.